Molybdenum recalls

The FDA has published 3 recalls involving Molybdenum since 2012. The latest was reported on 14 Aug 2019. Most were for sterility. RXQ Compounding has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 14 Aug 2019

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why molybdenum is recalled

Sterility3100%

Companies

RXQ Compounding133%
Medaus133%
Franck's Lab Inc., d.b.a. Franck's Compounding Lab133%

By year

2019133%
2016133%
2012133%

All molybdenum recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
14 Aug 2019Drug	CLASS II	Molybdenum 0.025MG/ML Injection Solution per vial recalled	RXQ Compounding	Sterility	Nationwide
20 Jul 2016Drug	CLASS II	Molybdenum 250MCG/ML (PF) Vials, Medaus Pharmacy recalled	Medaus	Sterility	Nationwide
22 Aug 2012Drug	CLASS II	Molybdenum 250mcg/ML Injectable (2 Different Products) recalled	Franck's Lab Inc., d.b.a. Franck's Compounding Lab	Sterility	Nationwide

Should you stop taking Molybdenum?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.